Carbamazepine Patent Expiration
Carbamazepine is Used for treating neurological and other disorders such as epilepsy with twice daily oral dosing. It was first introduced by Novartis Pharmaceuticals Corp
Carbamazepine Patents
Given below is the list of patents protecting Carbamazepine, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Carnexiv | US11529357 | Injectable carbamazepine composition essentially free of 10-bromo-carbamazepine | Jan 31, 2040 | Lundbeck Pharms Llc |
Carnexiv | US9493582 | Alkylated cyclodextrin compositions and processes for preparing and using the same | Feb 27, 2033 | Lundbeck Pharms Llc |
Carnexiv | US7635773 | Sulfoalkyl ether cyclodextrin compositions | Mar 13, 2029 | Lundbeck Pharms Llc |
Carnexiv | US8410077 | Sulfoalkyl ether cyclodextrin compositions | Mar 13, 2029 | Lundbeck Pharms Llc |
Carnexiv | US9750822 | Sulfoalkyl ether cyclodextrin compositions | Mar 13, 2029 | Lundbeck Pharms Llc |
Carnexiv | US9629797 | Parenteral carbamazepine formulation | Nov 10, 2028 | Lundbeck Pharms Llc |
Carnexiv | US9770407 | Parenteral carbamazepine formulation | Nov 10, 2028 | Lundbeck Pharms Llc |
Equetro | US6977253 | Methods for the treatment of bipolar disorder using carbamazepine |
May 19, 2024
(Expired) | Validus Pharms |
Carbatrol | US5912013 | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
Jun 15, 2016
(Expired) | Takeda Pharms Usa |
Equetro | US5912013 | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
Jun 15, 2016
(Expired) | Validus Pharms |
Carbamazepine's Family Patents

Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List